Results 121 to 130 of about 754,759 (237)
Health Science Reports, Volume 9, Issue 6, June 2026.ABSTRACT Background Dengue (DG) is a growing global public health threat. Bangladesh continues to endure an increasing burden despite persistent vector‐control initiatives. Effective DG prevention relies on adequate community knowledge, favorable attitudes, and sustained protective practices.
Abu Reza Md. Towfiqul Islam +2 more
wiley +1 more source
Pharmacy‐Based Immunization Delivery: A Comprehensive History and Current Challenges
JACCP: JOURNAL OF THE AMERICAN COLLEGE OF CLINICAL PHARMACY, Volume 9, Issue 6, June 2026.ABSTRACT Pharmacists and their teams have a long history of involvement with vaccines. This paper describes the contributions of pharmacy‐based immunization delivery in the United States from the 1800's to date. Early activities centered around storage and distribution of antitoxins and vaccines. From the 1950s through the early 1990s, pharmacists were
Jean‐Venable R. Goode +4 more
wiley +1 more source
Systematic review of studies evaluating the broader economic impact of vaccination in low and middle income countries. [PDF]
, 2012 BACKGROUND: Most health economic evaluations of childhood vaccination only capture the health and short-term economic benefits. Measuring broader, long-term effects of vaccination on productivity and externalities could provide a more complete picture of
Evers, Silvia; id_orcid +17 more
core +1 more source
Dengue Virus Infection: A Tale of Viral Exploitations and Host Responses
, 2021 Dengue is a mosquito-borne viral disease (arboviral) caused by the Dengue virus. It is one of the prominent public health problems in tropical and subtropical regions with no effective vaccines.
Anupam Mukherjee +4 more
core +1 more source
Reverse Genetics of Orthoflaviviruses: Strategies for Constructing Functional or Infectious cDNA
Journal of Medical Virology, Volume 98, Issue 6, June 2026.ABSTRACT Reverse genetics (RG) systems have transformed RNA virus research by enabling the recovery of recombinant viruses entirely from cloned cDNA. These platforms allow precise, hypothesis‐driven manipulation of viral genomes and support systematic phenotypic analyses in vitro and in vivo.
Young‐Min Lee
wiley +1 more source
Under-recognition and reporting of dengue in Cambodia: a capture–recapture analysis of the National Dengue [PDF]
, 2011 Robust disease burden estimates are important for decision-making concerning introduction of new vaccines. Dengue is a major public health problem in the tropics but robust disease burden estimates are lacking.
Margolis, H. S. +21 more
core +1 more source
Current prevention and potential treatment options for dengue infection
Journal of Pharmacy & Pharmaceutical Sciences, 2019 Currently, treatments for dengue infection are only symptomatic as no antiviral agents nor vaccines are available to combat this virus. Despite challenges faced by researchers, many efforts are ongoing to reduce cases of dengue infection either by ...
Malina Jasamai +3 more
doaj +1 more source
Organoids: From Bench to Bedside Applications
MedComm, Volume 7, Issue 6, June 2026.Organoids, as a groundbreaking biomedical research platform, utilize adult stem cells (ASCs), embryonic stem cells (ESCs), and induced pluripotent stem cells (iPSCs) as sources. By integrating specific growth and differentiation signals within an extracellular matrix (e.g., Matrigel), organoids guide cells to self‐assemble into three‐dimensional ...
Kelin Li +6 more
wiley +1 more source
Progress towards a dengue vaccine
The Lancet Infectious Diseases, 2009 The spread of dengue virus throughout the tropics represents a major, rapidly growing public health problem with an estimated 2.5 billion people at risk of dengue fever and the life-threatening disease, severe dengue. A safe and effective vaccine for dengue is urgently needed. The pathogenesis of severe dengue results from a complex interaction between
Webster, D, Farrar, J, Rowland-Jones, S
openaire +3 more sources